HomeHOSPITALS
HOSPITALS
Providence St Joseph Hospital Performs World’s First Spine Surgery Using eCential Robotics’ Open Spine Robot, with Spineart Compatible Implants
“In our relentless pursuit of innovation and excellence in patient care, we were eager to utilize the solutions provided by Spineart and eCential,” said Erick Westbroek*, M.D., Providence St Joseph spinal surgeon. “The integration of Spineart's advanced implant system with eCential's open robotic platform will enable us to perform minimally invasive surgeries with high predictability, reproducibility and outcomes.”
Delray Medical Center | 1st Hospital in Florida to Use Innovative Treatment for Abdominal Aortic Aneurysm
“We are proud that Dr. Ricotta, a highly respected member of the Delray Medical Center Medical Staff, was selected to participate in this important clinical trial and we congratulate him on being the first surgeon in Florida to achieve this medical milestone,” said Heather Haverciak, the hospital’s CEO. “If proven safe and effective, this therapy has the potential to profoundly impact patients living with aneurysmal disease.”
Tampa General Hospital Researchers Develop Innovative Device That Expands Access to Heart Transplants
"Our goal is to expand access to world-class care and save more lives," said John Couris, president and CEO of Tampa General Hospital. "With innovative approaches to transplantation, we can extend the life of critical organs and improve patient outcomes. This grant will advance our research efforts, directly impacting the patients we serve."
Paige Reports 3 UK-Based Hospital Systems Exploring the Power of their AI for Diagnosing Prostate Cancer in Live Clinical Settings
The Paige Prostate Suite is a system of diagnostic AI applications designed to help pathologists detect, grade and measure tumours in prostate biopsies and tissue samples. Pathologists at these three hospital systems are assessing how Paige Prostate Suite impacts their clinical decision-making, pathology service delivery, and use of resources in a real-world setting.
Gwen Stefani Headlined the 19th Annual Feinstein Summer Concert | Raises $3.6M to Support Medical Innovation
Grammy Award-winning, multiplatinum-selling global singer-songwriter Gwen Stefani headlined the 19th annual Feinstein Summer Concert, which raised $3.6 million to advance scientific discovery at Northwell Health’s Feinstein Institutes for Medical Research.
Northwell Selected by CMS to test Medicare dementia care program
“Northwell and its team of clinicians with expertise in memory evaluation and management are excited to be selected as an established GUIDE Model site,” said Maria Torroella Carney, MD, division chief of Geriatrics and Palliative Medicine at Northwell. “It’s our hope to provide some relief and support to individuals and their loved ones throughout their journey with dementia and as they face other health issues.”
Morton Plant Hospital First in Tampa Bay to Use New Treatment for Restenosis
The new drug-coated balloon, AGENT™ from Boston Scientific, was approved by the U.S. Food and Drug Administration (FDA) for commercial use in March. The balloon catheter, the first drug-coated coronary balloon in the United States, reopens the narrowed stent and releases the high concentration of drugs to prevent scar tissue from forming and blocking the artery wall again.
Northwell Cardiothoracic Programs Have Nation’s Highest Success Rates
5 Northwell Cardiothoracic Programs (Northwell) include: Long Island Jewish Hospital, Lenox Hill Hospital, South Shore University Hospital, Staten Island University Hospital and the Sandra Atlas Bass Heart Hospital at North Shore University Hospital – received three-star ratings in their respective fields – the highest quality rating possible.
COTA, Baptist Health South Florida, and PreciseDx Announce Collaboration on the AI-Enabled Breast Cancer Recurrence Risk Assessment, PreciseBreast™
“AI has the potential to augment human learning and improve the accuracy and precision of cancer diagnostics and treatments,” said Dr. C.K. Wang, chief medical officer, COTA. “It is critical that we evaluate these tools against the current standard of care to validate their efficacy and build trust in AI and new technologies.”
AscellaHealth CEO, Dea Belazi, Honored as a 2024 PM360 Elite 100 Winner
Dea Belazi said, "This honor truly belongs to the entire AscellaHealth team in recognition of their expertise, dedication and ongoing work that enables patients with complex, chronic conditions to access specialty pharmaceuticals and novel therapies that enhance clinical outcomes."
Recent News
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”